Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study

SIMPLE SUMMARY: During the SARS-CoV-2 pandemic, lung cancer patients have been considered an especially vulnerable population and have been prioritized for vaccination. However, several aspects (degree of immunity, potential interaction with active anticancer therapy, safety, and tolerability of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Ainhoa, Boigues, Marc, Felip, Eudald, Cucurull, Marc, Notario, Lucia, Pous, Anna, Torres, Pere, Benitez, Marta, Rodriguez, Marina, Quirant, Bibiana, Romeo, Margarita, Fuster, Daniel, Moran, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817972/
https://www.ncbi.nlm.nih.gov/pubmed/36612134
http://dx.doi.org/10.3390/cancers15010137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817972/
https://www.ncbi.nlm.nih.gov/pubmed/36612134
http://dx.doi.org/10.3390/cancers15010137

Ejemplares similares